Dr. William Mark McCollough, MD

Dr. McCollough practices at Mission Hospital in Asheville, North Carolina, part of HCA Healthcare.

Dr. McCollough's NPI, 1881674992, was assigned on January 17, 2006. Dr. McCollough graduated from University of Florida College of Medicine in 1985. Dr. McCollough holds North Carolina license 200300500.

Dr. McCollough's primary practice is Mission Hospital, at 509 Biltmore Ave, Asheville, NC 28801 in Buncombe County. The practice phone is (828) 213-1111.

Dr. McCollough's primary practice is Mission Hospital in Asheville, North Carolina, part of HCA Healthcare. Dr. McCollough is also affiliated with CarePartners Rehabilitation Hospital. The medical group on file is Mission Health Community Multispecialty Providers. Dmand AI also links Dr. McCollough to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCollough practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. McCollough's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. McCollough is licensed in North Carolina.

CMS data shows 1,302 Medicare services from Dr. McCollough across 14 procedure codes in 2024, for 196 Medicare patients. Medicare paid $88,112 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 196 Medicare patients who saw Dr. McCollough in 2024. The largest group is 65 to 74, with 96 patients. 72% of them have cancer, and 70% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McCollough's median patient age at 73, with 42% women.

In 2024, Dr. McCollough wrote 188 Medicare Part D claims for 77 patients. 91% of them were for generic drugs. CMS names the drug for 117 of them, across 7 drugs with 11 or more claims each, at $1,466 in total drug cost. In 2023, CMS named 32 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. McCollough for performance year 2024, reported through an alternative payment model (APM). Dr. McCollough accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. McCollough to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 5 general payments to Dr. McCollough from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Servier Pharmaceuticals LLC paid the most, $962.

Dr. McCollough graduated from University of Florida College of Medicine in 1985.